LORICRIN and Alzheimer disease: Skin barrier dysfunction is a hallmark of AD pathogenesis, in which the dysregulation of antimicrobial peptides and barrier-related proteins such as filaggrin, loricrin, claudin-1, and ZO-1 (namely, TJP-1) play crucial roles [19].